LumiThera Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
21
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$178M
LumiThera General Information
Description
Developer of medical devices intended to prevent vision loss and blindness. The company's offerings include photobiomodulation treatments using non-invasive light-emitting diodes for acute and chronic ocular diseases and disorders, improving visual acuity and contrast sensitivity and reducing central drusen volume, enabling healthcare providers to provide better treatment for dry age-related muscular degeneration.
Contact Information
Website
www.lumithera.com(Operating Subsidiary)
Corporate Office
- 19578 10th Avenue North East
- Suite 200
- Poulsbo, WA 98370
- United States
Corporate Office
- 19578 10th Avenue North East
- Suite 200
- Poulsbo, WA 98370
- United States
LumiThera Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Merger/Acquisition | 02-Sep-2025 | $178M | Completed | Clinical Trials - General | ||
| 13. Later Stage VC (Series C1) | 26-Feb-2025 | Completed | Clinical Trials - General | |||
| 12. Later Stage VC (Series C1) | 01-May-2023 | Completed | Clinical Trials - General | |||
| 11. Later Stage VC (Series C1) | 19-Oct-2021 | Completed | Clinical Trials - General | |||
| 10. Secondary Transaction - Private | Completed | Clinical Trials - General | ||||
| 9. Grant | 03-Sep-2020 | Completed | Clinical Trials - General | |||
| 8. Later Stage VC (Series C) | 01-Sep-2020 | Completed | Clinical Trials - General | |||
| 7. Grant | 26-Feb-2019 | Completed | Clinical Trials - General | |||
| 6. Angel (individual) | 01-Jan-2019 | $9.7M | Completed | Clinical Trials - General | ||
| 5. Early Stage VC (Series B) | 13-Jul-2017 | $5.5M | $9.7M | Completed | Clinical Trials - General |
LumiThera Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C-1 | ||||||||
| Series C | ||||||||
| Series B | 3,600,000 | $0.001000 | 6% | $1.54 | $1.54 | 1x | $1.54 | 11.55% |
| Series A | 3,500,000 | $0.001000 | 6% | $1.11 | $1.11 | 1x | $1.11 | 11.23% |
LumiThera Comparisons
Industry
Financing
Details
LumiThera Competitors (8)
One of LumiThera’s 8 competitors is LIGHTMED, a Corporation company based in San Clemente, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| LIGHTMED | Corporation | San Clemente, CA | ||||
| Konan Medical | Corporation | Irvine, CA | ||||
| MuReva Phototherapy | Venture Capital-Backed | Brecksville, OH | ||||
| NeoMedLight | Venture Capital-Backed | Villeurbanne, France | ||||
| Ceribell | Formerly VC-backed | Sunnyvale, CA |
LumiThera Patents
LumiThera Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210059858-A1 | Methods for preventing and treating ocular disease | Inactive | 04-Sep-2019 | ||
| WO-2019090159-A1 | Methods for treating ocular disease | Inactive | 02-Nov-2017 | ||
| JP-2017530774-A | Multi-wavelength phototherapy apparatus, system and method for non-invasive treatment of damaged or diseased tissue | Active | 09-Sep-2014 | ||
| JP-2026086468-A | Multi-wavelength phototherapy device, system and method for non-invasive treatment of damaged or diseased tissue | Pending | 09-Sep-2014 | ||
| ES-2837061-T3 | Multi-wavelength phototherapy devices for non-invasive treatment of diseased or damaged tissue | Active | 09-Sep-2014 | A61F9/0079 |
LumiThera Signals
LumiThera Former Investors (20)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 3E Bioventures Capital | Venture Capital | Minority | ||
| Angels + Life.Sci Investors Network | Angel Group | Minority | ||
| Ark Canada Investment Group | Family Office | Minority | ||
| Celeste Management | Family Office | Minority | ||
| Denniston Family Office | Family Office | Minority |
LumiThera Acquisitions (2)
LumiThera’s most recent deal was a Merger/Acquisition with MacuLogix. The deal was made on 26-Jul-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| MacuLogix | 26-Jul-2022 | Merger/Acquisition | Diagnostic Equipment | ||
| Diopsys | 05-Mar-2022 | Merger/Acquisition | Diagnostic Equipment |
LumiThera FAQs
-
When was LumiThera founded?
LumiThera was founded in 2013.
-
Where is LumiThera headquartered?
LumiThera is headquartered in Poulsbo, WA.
-
What is the size of LumiThera?
LumiThera has 21 total employees.
-
What industry is LumiThera in?
LumiThera’s primary industry is Other Devices and Supplies.
-
Is LumiThera a private or public company?
LumiThera is a Private company.
-
What is the current valuation of LumiThera?
The current valuation of LumiThera is .
-
What is LumiThera’s current revenue?
The current revenue for LumiThera is .
-
How much funding has LumiThera raised over time?
LumiThera has raised $39.3M.
-
Who are LumiThera’s investors?
3E Bioventures Capital, Angels + Life.Sci Investors Network, Ark Canada Investment Group, Celeste Management, and Denniston Family Office are 5 of 20 investors who have invested in LumiThera.
-
Who are LumiThera’s competitors?
LIGHTMED, Konan Medical, MuReva Phototherapy, NeoMedLight, and Ceribell are some of the 8 competitors of LumiThera.
-
When was LumiThera acquired?
LumiThera was acquired on 02-Sep-2025.
-
Who acquired LumiThera?
LumiThera was acquired by Alcon.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process